We are live on ! Find out more
NPCE icon

Neuropace
NPCE

80 hedge funds and large institutions have $268M invested in Neuropace in 2025 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 21

9.81% more ownership

Funds ownership: 68.62% → 78.43% (+9.8%)

7% more capital invested

Capital invested by funds: $251M → $268M (+$16.8M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less call options, than puts

Call options by funds: $209K | Put options by funds: $226K

18% less funds holding

Funds holding: 98 → 80 (-18)

64% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 28

Holders
80
Holders Change
-18
Holders Change %
-18.37%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
10
Increased
33
Reduced
21
Closed
28
Calls
$209K
Puts
$226K
Net Calls
-$17K
Net Calls Change
-$34.2M

Top Buyers

Rank Fund Capital Flow
1
PCH
Polar Capital Holdings
United Kingdom
+$29.2M
2
SCM
Soleus Capital Management
Connecticut
+$6.08M
3
AC
Armistice Capital
New York
+$1.37M
4
EIM
Essex Investment Management
Massachusetts
+$1.35M
5
Goldman Sachs
Goldman Sachs
New York
+$1.21M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$5.57M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$4.46M
3
CSS
Cubist Systematic Strategies
Connecticut
-$1.07M
4
Two Sigma Investments
Two Sigma Investments
New York
-$654K
5
DCM
Driehaus Capital Management
Illinois
-$621K
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
26
Algert Global
California
$1M +$84.3K +8,939 +10%
Charles Schwab
27
Charles Schwab
California
$710K – – –
Russell Investments Group
28
Russell Investments Group
United Kingdom
$693K -$40.1K -4,255 -6%
UBS Group
29
UBS Group
Switzerland
$673K +$360K +38,203 +141%
Barclays
30
Barclays
United Kingdom
$670K -$63K -6,677 -9%
LCM
31
Legato Capital Management
California
$650K +$390K +41,323 +190%
HWM
32
HighMark Wealth Management
Minnesota
$650K – – –
Squarepoint
33
Squarepoint
New York
$635K +$295K +31,267 +103%
PAM
34
Panagora Asset Management
Massachusetts
$615K -$378K -40,094 -40%
Bank of America
35
Bank of America
North Carolina
$595K +$105K +11,124 +24%
TI
36
Trexquant Investment
Connecticut
$588K +$115K +12,206 +27%
HSBC Holdings
37
HSBC Holdings
United Kingdom
$565K -$44.3K -4,694 -8%
GCP
38
GSA Capital Partners
United Kingdom
$562K +$12.5K +1,323 +2%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$539K +$2.85K +302 +0.6%
Walleye Capital
40
Walleye Capital
New York
$531K +$176K +18,643 +57%
Principal Financial Group
41
Principal Financial Group
Iowa
$407K +$202K +21,439 +119%
Two Sigma Advisers
42
Two Sigma Advisers
New York
$393K -$19.8K -2,100 -5%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$330K -$46.4K -4,923 -13%
N
44
Nuveen
North Carolina
$322K – – –
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$308K +$206K +21,831 +274%
Los Angeles Capital Management
46
Los Angeles Capital Management
California
$272K +$249K +26,390 New
WWM
47
Western Wealth Management
Colorado
$237K +$217K +23,000 New
PA
48
PharVision Advisers
Florida
$232K +$212K +22,456 New
ACM
49
Aquatic Capital Management
Illinois
$229K +$209K +22,215 New
Wells Fargo
50
Wells Fargo
California
$206K +$39.1K +4,145 +26%
1
2
3 4 5

NPCE Hedge Fund Activity: Q3 2025 in Review

80 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Neuropace (NPCE) for Q3 2025, worth a combined $268M — up 6.7% from $251M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of NPCE and 10 opened new positions — a net loss of 18 holders — while 21 trimmed existing stakes and 33 added.

The largest buyer was Polar Capital Holdings, opening a new position worth an estimated $29.2M. The largest seller was Deerfield Management, exiting entirely with an estimated $5.57M sold.

  • 80 institutional investors held Neuropace (NPCE) as of Q3 2025, down from 98 in Q2 2025.
  • Funds reported $268M of Neuropace stock for Q3 2025, up 6.7% quarter-over-quarter.
  • 10 funds opened new Neuropace positions in Q3 2025 and 28 closed out, a net change of -18 holders.
  • The largest Neuropace buyer in Q3 2025 was Polar Capital Holdings, an estimated $29.2M added.
  • The largest Neuropace seller in Q3 2025 was Deerfield Management, an estimated $5.57M sold.

Based on aggregated 13F filings for Q3 2025.